S

Shandong Sinobioway Biomedicine Co Ltd
SZSE:002581

Watchlist Manager
Shandong Sinobioway Biomedicine Co Ltd
SZSE:002581
Watchlist
Price: 10.9 CNY 0.18% Market Closed
Market Cap: 7.2B CNY
Have any thoughts about
Shandong Sinobioway Biomedicine Co Ltd?
Write Note

Profitability Summary

30/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Shandong Sinobioway Biomedicine Co Ltd

Revenue
431.4m CNY
Cost of Revenue
-91.1m CNY
Gross Profit
340.3m CNY
Operating Expenses
-740.9m CNY
Operating Income
-400.7m CNY
Other Expenses
92.3m CNY
Net Income
-308.3m CNY

Margins Comparison
Shandong Sinobioway Biomedicine Co Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CN
Shandong Sinobioway Biomedicine Co Ltd
SZSE:002581
7.2B CNY
79%
-93%
-71%
ZA
Sasol Ltd
JSE:SOL
51.9B Zac
50%
16%
-16%
DE
Basf Se
XETRA:BAS
38.1B EUR
25%
2%
0%
IN
Pidilite Industries Ltd
NSE:PIDILITIND
1.5T INR
54%
20%
15%
CN
Ningxia Baofeng Energy Group Co Ltd
SSE:600989
119.4B CNY
31%
26%
19%
ZA
Omnia Holdings Ltd
JSE:OMN
12.2B Zac
23%
8%
5%
IN
SRF Ltd
NSE:SRF
671.2B INR
38%
13%
8%
JP
Mitsubishi Chemical Holdings Corp
TSE:4188
1.1T JPY
27%
7%
2%
JP
Mitsubishi Chemical Group Corp
F:M3C0
6.5B EUR
27%
7%
2%
FR
Arkema SA
PAR:AKE
5.3B EUR
20%
8%
4%
JP
Resonac Holdings Corp
XMUN:SWD
4.4B EUR
23%
4%
3%
Country CN
Market Cap 7.2B CNY
Gross Margin
79%
Operating Margin
-93%
Net Margin
-71%
Country ZA
Market Cap 51.9B Zac
Gross Margin
50%
Operating Margin
16%
Net Margin
-16%
Country DE
Market Cap 38.1B EUR
Gross Margin
25%
Operating Margin
2%
Net Margin
0%
Country IN
Market Cap 1.5T INR
Gross Margin
54%
Operating Margin
20%
Net Margin
15%
Country CN
Market Cap 119.4B CNY
Gross Margin
31%
Operating Margin
26%
Net Margin
19%
Country ZA
Market Cap 12.2B Zac
Gross Margin
23%
Operating Margin
8%
Net Margin
5%
Country IN
Market Cap 671.2B INR
Gross Margin
38%
Operating Margin
13%
Net Margin
8%
Country JP
Market Cap 1.1T JPY
Gross Margin
27%
Operating Margin
7%
Net Margin
2%
Country JP
Market Cap 6.5B EUR
Gross Margin
27%
Operating Margin
7%
Net Margin
2%
Country FR
Market Cap 5.3B EUR
Gross Margin
20%
Operating Margin
8%
Net Margin
4%
Country JP
Market Cap 4.4B EUR
Gross Margin
23%
Operating Margin
4%
Net Margin
3%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Shandong Sinobioway Biomedicine Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CN
Shandong Sinobioway Biomedicine Co Ltd
SZSE:002581
7.2B CNY
-14%
-12%
-17%
-19%
ZA
Sasol Ltd
JSE:SOL
51.9B Zac
-26%
-11%
14%
19%
DE
Basf Se
XETRA:BAS
38.1B EUR
0%
0%
2%
0%
IN
Pidilite Industries Ltd
NSE:PIDILITIND
1.5T INR
24%
16%
29%
21%
CN
Ningxia Baofeng Energy Group Co Ltd
SSE:600989
119.4B CNY
16%
8%
14%
10%
ZA
Omnia Holdings Ltd
JSE:OMN
12.2B Zac
12%
7%
17%
11%
IN
SRF Ltd
NSE:SRF
671.2B INR
10%
6%
12%
8%
JP
Mitsubishi Chemical Holdings Corp
TSE:4188
1.1T JPY
5%
2%
7%
4%
JP
Mitsubishi Chemical Group Corp
F:M3C0
6.5B EUR
5%
2%
7%
4%
FR
Arkema SA
PAR:AKE
5.3B EUR
5%
2%
6%
5%
JP
Resonac Holdings Corp
XMUN:SWD
4.4B EUR
7%
2%
4%
5%
Country CN
Market Cap 7.2B CNY
ROE
-14%
ROA
-12%
ROCE
-17%
ROIC
-19%
Country ZA
Market Cap 51.9B Zac
ROE
-26%
ROA
-11%
ROCE
14%
ROIC
19%
Country DE
Market Cap 38.1B EUR
ROE
0%
ROA
0%
ROCE
2%
ROIC
0%
Country IN
Market Cap 1.5T INR
ROE
24%
ROA
16%
ROCE
29%
ROIC
21%
Country CN
Market Cap 119.4B CNY
ROE
16%
ROA
8%
ROCE
14%
ROIC
10%
Country ZA
Market Cap 12.2B Zac
ROE
12%
ROA
7%
ROCE
17%
ROIC
11%
Country IN
Market Cap 671.2B INR
ROE
10%
ROA
6%
ROCE
12%
ROIC
8%
Country JP
Market Cap 1.1T JPY
ROE
5%
ROA
2%
ROCE
7%
ROIC
4%
Country JP
Market Cap 6.5B EUR
ROE
5%
ROA
2%
ROCE
7%
ROIC
4%
Country FR
Market Cap 5.3B EUR
ROE
5%
ROA
2%
ROCE
6%
ROIC
5%
Country JP
Market Cap 4.4B EUR
ROE
7%
ROA
2%
ROCE
4%
ROIC
5%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More
Back to Top